LDL oxidation is associated with increased blood hemoglobin A1c levels in diabetic patients

Clinica Chimica Acta

Volumn 377, Issue 1-2, 2007, Pages 114-118

  Hussein, Osamah A ^a   Gefen, Yacob ^a   Zidan, Jamal M ^a   Karochero, Ernest Y ^a   Luder, Anthony S ^b   Assy, Nimer N ^a   Sror, Elyas S ^b   Aviram, Michael Y ^c  

^a Rebecca Sieff Government Hospital   (Israel)

^b Kupat Holim Klalit   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

HbA1c; Oxidized LDL; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISCRIMINANT ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HEMOLYSATE; HUMAN; LIPID OXIDATION; LIPID PEROXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

DIABETES MELLITUS; FEMALE; HEMOGLOBINS; HUMANS; LIPOPROTEINS, LDL; MIDDLE AGED; OXIDATION-REDUCTION;

EID: 33845443773     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.09.002     Document Type: Article

References (46)

1. Kesavulu M.M., Giri R., Kameswara Rao B., and Apparao C. lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab 26 (2000) 387-392
2. The DCCT Research group. Diabetes control and complications trial (DCCT): results of feasibility study. Diabetes Care 10 (1987) 1-19
3. Bunn H.F. Evaluation of glycosylated hemoglobin in diabetic patients. Diabetes 30 (1981) 613-617
4. Higgins P.J., and Bunn H.F. Kinetic analysis of the non enzymatic glycosylation of hemoglobin. J Biol Chem 256 (1981) 5204-5208
5. Mazzanti L., Faloia E., Rabini R.A., et al. Diabetes mellitus induces red blood cell plasma membrane alterations possibly affecting the aging process. Clin Biochem 25 (1992) 41-46
6. Service F.J. Correlation between glycemia and glycated hemoglobin. Compr Ther 16 (1990) 33-40
7. Komosinska-Vassev K., Olczyk K., Olczyk P., and Winsz-Szczotka K. Effects of metabolic control and vascular complications on indices of oxidative stress in type 2 diabetic patients. Diabetes Res Clin Pract 68 (2005) 207-216
8. Derr R., Garrett E., Stacy G.A., and Saudek C.D. Is HbA1c affected by glycemic instability?. Diabetes Care 26 (2003) 2728-2733
9. Lyons T.J. Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol 71 (1993) 26B-31B
10. Selvaraj N., Bobby Z., Das A.K., Ramesh R., and Koner B.C. An evaluation of level of oxidative stress and protein glycation in nondiabetic undialyzed chronic renal failure patients. Clin Chim Acta 324 (2002) 45-50
11. Mohan Kumar K.M., Bobby Z., Selvaraj N., et al. Possible link between glycated hemoglobin and lipid peroxidation in hyperthyroidism. Clin Chim Acta 342 (2004) 187-192
12. Selvaraj N., Bobby Z., Koner B.C., and Das A.K. Reassessing the increased glycation of hemoglobin in nondiabetic chronic renal failure patients: a hypothesis on the role of lipid peroxides. Clin Chim Acta 360 (2005) 108-113
13. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., and Witztum J.L. Beyond cholesterol. Modifications of low density lipoprotein that increase its atherogenicity. New Engl J Med 320 (1989) 915-924
14. Aviram M., and Rosenblat M. Oxidative stress in cardiovascular disease: role of oxidized lipoproteins in macrophage foam cell formation and atherosclerosis. In: Fuchs J., Podda M., and Packer L. (Eds). Redox Genome Interactions in Health and Disease (2004), Marcel Dekker, NY 557-590
15. Davi G., Falco A., and Patrono C. Lipid peroxidation in diabetes mellitus. Antioxid Redox Signal 7 (2005) 256-268
16. Ceriello A. The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications. Diabetologia 46 (2003) M9-M16
17. De Rijke Y.B., Verwey H.F., Vogelezang C.J., et al. Enhanced susceptibility of low-density lipoproteins to oxidation in coronary bypass patients with progression of atherosclerosis. Clin Chim Acta 243 (1995) 137-149
18. van de Vijver L.P., Kardinaal A.F., van Duyvenvoorde W., et al. LDL oxidation and extent of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 18 (1998) 193-199
19. Aviram M. Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. Biochem Med 30 (1983) 111-118
20. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
21. Aviram M., and Vaya J. Markers for low-density lipoprotein oxidation. Methods Enzymol 335 (2001) 244-256
22. Esterbauer H., Striegl G., Puhl H., and Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 6 (1989) 67-75
23. Makimattila S., Liu M., Vakkilainen J., et al. Impaired endothelium-dependent vasodilation in type 2 diabetes. Diabetes Care 22 (1999) 973-981
24. Wen Y., Skidmore J.C., Porter-Turner M.M., Rea C.A., Khokher M.A., and Singh B.M. Relationship of glycation, antioxidant status and oxidative stress to vascular endothelial damage in diabetes. Diabetes Obes Metab 4 (2002) 305-308
25. Bierman E.L. George Lyman Duff Memorial Lecture. Atherogenesis in diabetes. Arterioscler Thromb 12 (1992) 647-656
26. Kawamura M., Heinecke J.W., and Chait A. Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. J Clin Invest 94 (1994) 771-778
27. Ruiz C., Alegria A., Barbera R., Farre R., and Lagarda M.J. Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus. Scand J Clin Lab Invest 59 (1999) 99-105
28. Altomare E., Vendemiale G., Chicco D., Procacci V., and Cirelli F. Increased lipid peroxidation in type 2 poorly controlled diabetic patients. Diabete Metab 18 (1992) 264-271
29. Velazquez E., Winocour P.H., Kesteven P., Alberti K.G., and Laker M.F. Relation of lipid peroxides to macrovascular disease in type 2 diabetes. Diabet Med 8 (1991) 752-758
30. Cakatay U. Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab 31 (2005) 551-557
31. Armstrong D., Abdella N., Salman A., Miller N., Rahman E.A., and Bojancyzk M. Relationship of lipid peroxides to diabetic complications. Comparison with conventional laboratory tests. J Diabetes Complications 6 (1992) 116-122
32. Turkina T.I., Marchenko L.F., Zezerov A.E., Pozniak T.I., Martynova M.I., and Kiseleva E.V. The indices of the lipid peroxidation and desaturation of the blood serum in diabetes mellitus in children. Probl Endokrinol (Mosk) 37 (1991) 13-15
33. Gambino R., Uberti B., Alemanno N., Pisu E., Pagano G., and Cassader M. In vivo oxidizability of LDL in type 2 diabetic patients in good and poor glycemic control. Atherosclerosis 173 (2004) 103-107
34. Slatter D.A., Bolton C.H., and Baily A.J. The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia 43 (2000) 550-557
35. Nair V., Vietti D.E., and Cooper C.S. Degenerative chemistry of malondialdehyde-structure, stereochemistry, and kinetics of formation of enaminals from reaction with amino acids. J Am Chem Soc 103 (1981) 3030-3036
36. Scheffer P.G., Bos G., Volwater H.G., Dekker J.M., Heine R.J., and Teerlink T. Associations of LDL size with in vitro oxidizability and plasma levels of in vivo oxidized LDL in type 2 diabetic patients. Diabet Med 20 (2003) 563-567
37. Kilpatrick E.S., Maylor P.W., and Keevil B.G. Biological variation of glycated hemoglobin. Implication for diabetes screening and monitoring. Diabetes Care 21 (1998) 261-264
38. Rohlfing C., Wiedmeyer H.M., Little R., et al. Biological variation of glycohemoglobin. Clin Chem 48 (2002) 1116-1118
39. Snieder H., Sawtell P.A., Ross L., Walker J., Spector T.D., and Leslie R.D. HbA1c levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes 50 (2001) 2858-2863
40. Gould B.J., Davie S.J., and Yudkin J.S. Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Clin Chim Acta 260 (1997) 49-64
41. Hudson P.R., Child D.F., Jones H., and Williams C.P. Differences in rates of glycation (Glycation index) may significantly affect individual HbA1c results in type 1 diabetes. Ann Clin Biochem 36 (1999) 451-459
42. Szwergold B.S., and Beisswenger P.J. Enzymatic deglycation - a new paradigm or an epiphenomenon?. Biochem Soc Trans 31 (2003) 1428-1432
43. Hempe J.M., Gomez R., McCarter Jr. R.J., and Chalew S.A. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications 16 (2002) 313-320
44. Shurtz-Swirski R., Sela S., Herskovits A.T., et al. Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients. Diabetes Care 24 (2001) 104-110
45. Young I.S., Tate S., Lightbody J.H., McMaster D., and Trimble E.R. The effects of desferrioxamine and ascorbate on oxidative stress in the streptozotocin diabetic rat. Free Radic Biol Med 18 (1995) 833-840
46. Rodriguez-Manas L., Angulo J., Peiro C., et al. Endothelial dysfunction and metabolic control in streptozotocin-induced diabetic rats. Br J Pharmacol 123 (1998) 1495-1502